Hestia Insight Inc. (HSTA)
Hestia Insight Inc. operates in the Software - Application industry of the Technology sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.03, up 0.00% on the session, giving a market capitalisation of $921,996. On trailing twelve-month figures it carries a trailing P/E of -1.18, a net margin of -4860.4%. Its beta of 0.20 implies it has historically moved less than the broad market.
Hestia Insight Inc. delivers specialized strategic consulting and capital market advisory support, primarily catering to small to mid-sized businesses within the healthcare, biotech, and fintech sectors. The company's service portfolio also extends to healthcare management and patient-focused solutions. Moreover, Hestia Insight Inc. is involved in creating and analyzing healthcare technologies, specifically those related to neurological and psychiatric conditions. Completing its range of services, the firm provides management and assistance for medical supply sales, alongside comprehensive sales and marketing strategy and guidance. Formerly known as Luxshmi Investments, Inc., the company officially rebranded to Hestia Insight Inc. in May 2019. It operates from its headquarters in Las Vegas, Nevada.
Hestia Insight Inc. is most often compared with the following Technology names: